{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T15:07:25Z","timestamp":1768835245222,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T00:00:00Z","timestamp":1655510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T00:00:00Z","timestamp":1655510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s10557-022-07349-5","type":"journal-article","created":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T02:02:31Z","timestamp":1655517751000},"page":"1087-1101","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hyperglycemia-Induced Overexpression of PH Domain Leucine-Rich Repeat Protein Phosphatase 1 (PHLPP1) Compromises the Cardioprotective Effect of Ischemic Postconditioning Via Modulation of the Akt\/Mst1 Pathway Signaling"],"prefix":"10.1007","volume":"37","author":[{"given":"Yun","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuming","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajuan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianshu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1697-0557","authenticated-orcid":false,"given":"Sumin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,18]]},"reference":[{"issue":"8","key":"7349_CR1","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","volume":"143","author":"SS Virani","year":"2021","unstructured":"Virani SS, Alonso A, Aparicio HJ, et al. Heart disease and stroke statistics-2021 update: a report from the american heart association. Circulation. 2021;143(8):e254\u2013743.","journal-title":"Circulation"},{"issue":"23","key":"7349_CR2","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1093\/eurheartj\/eht090","volume":"34","author":"GM Frohlich","year":"2013","unstructured":"Frohlich GM, Meier P, White SK, Yellon DM, Hausenloy DJ. Myocardial reperfusion injury: looking beyond primary PCI. Eur Heart J. 2013;34(23):1714\u201322.","journal-title":"Eur Heart J"},{"issue":"4","key":"7349_CR3","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s12265-018-9813-1","volume":"11","author":"JH Rosenberg","year":"2018","unstructured":"Rosenberg JH, Werner JH, Moulton MJ, Agrawal DK. Current modalities and mechanisms underlying cardioprotection by ischemic conditioning. J Cardiovasc Transl Res. 2018;11(4):292\u2013307.","journal-title":"J Cardiovasc Transl Res"},{"issue":"3","key":"7349_CR4","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1159\/000481755","volume":"43","author":"S Gao","year":"2017","unstructured":"Gao S, Zhan L, Yang Z, et al. Remote limb ischaemic postconditioning protects against myocardial ischaemia\/reperfusion injury in mice: activation of JAK\/STAT3-mediated Nrf2-antioxidant signalling. Cell Physiol Biochem. 2017;43(3):1140\u201351.","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"7349_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s13105-019-00664-w","volume":"75","author":"S Tyagi","year":"2019","unstructured":"Tyagi S, Singh N, Virdi JK, Jaggi AS. Diabetes abolish cardioprotective effects of remote ischemic conditioning: evidences and possible mechanisms. J Physiol Biochem. 2019;75(1):19\u201328.","journal-title":"J Physiol Biochem"},{"issue":"3","key":"7349_CR6","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.cardiores.2003.09.024","volume":"61","author":"DJ Hausenloy","year":"2004","unstructured":"Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res. 2004;61(3):448\u201360.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"7349_CR7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1161\/01.RES.0000138303.76488.fe","volume":"95","author":"A Tsang","year":"2004","unstructured":"Tsang A, Hausenloy DJ, Mocanu MM, Yellon DM. Postconditioning: a form of \"modified reperfusion\" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res. 2004;95(3):230\u20132.","journal-title":"Circ Res"},{"issue":"23","key":"7349_CR8","doi-asserted-by":"publisher","first-page":"5312","DOI":"10.1111\/bph.14993","volume":"177","author":"C Penna","year":"2020","unstructured":"Penna C, Andreadou I, Aragno M, et al. Effect of hyperglycaemia and diabetes on acute myocardial ischaemia-reperfusion injury and cardioprotection by ischaemic conditioning protocols. Br J Pharmacol. 2020;177(23):5312\u201335.","journal-title":"Br J Pharmacol"},{"key":"7349_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jss.2017.12.030","volume":"225","author":"Y Qiu","year":"2018","unstructured":"Qiu Y, Wu Y, Meng M, et al. GYY4137 protects against myocardial ischemia\/reperfusion injury via activation of the PHLPP-1\/Akt\/Nrf2 signaling pathway in diabetic mice. J Surg Res. 2018;225:29\u201339.","journal-title":"J Surg Res"},{"key":"7349_CR10","doi-asserted-by":"publisher","first-page":"6657529","DOI":"10.1155\/2021\/6657529","volume":"2021","author":"S Gao","year":"2021","unstructured":"Gao S, Wang R, Dong S, et al. Inactivation of TOPK caused by hyperglycemia blocks diabetic heart sensitivity to sevoflurane postconditioning by impairing the PTEN\/PI3K\/Akt signaling. Oxid Med Cell Longev. 2021;2021:6657529.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"7349_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.molcel.2005.03.008","volume":"18","author":"T Gao","year":"2005","unstructured":"Gao T, Furnari F, Newton AC. PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol Cell. 2005;18(1):13\u201324.","journal-title":"Mol Cell."},{"issue":"6","key":"7349_CR12","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1042\/BST20160170","volume":"44","author":"AT Grzechnik","year":"2016","unstructured":"Grzechnik AT, Newton AC. PHLPPing through history: a decade in the life of PHLPP phosphatases. Biochem Soc Trans. 2016;44(6):1675\u201382.","journal-title":"Biochem Soc Trans"},{"issue":"4","key":"7349_CR13","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1161\/CIRCRESAHA.109.215020","volume":"107","author":"S Miyamoto","year":"2010","unstructured":"Miyamoto S, Purcell NH, Smith JM, et al. PHLPP-1 negatively regulates Akt activity and survival in the heart. Circ Res. 2010;107(4):476\u201384.","journal-title":"Circ Res"},{"issue":"7","key":"7349_CR14","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.cellsig.2007.12.019","volume":"20","author":"P Ling","year":"2008","unstructured":"Ling P, Lu TJ, Yuan CJ, Lai MD. Biosignaling of mammalian Ste20-related kinases. Cell Signal. 2008;20(7):1237\u201347.","journal-title":"Cell Signal"},{"issue":"4","key":"7349_CR15","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.molcel.2010.03.017","volume":"38","author":"M Qiao","year":"2010","unstructured":"Qiao M, Wang Y, Xu X, et al. Mst1 is an interacting protein that mediates PHLPPs\u2019 induced apoptosis. Mol Cell. 2010;38(4):512\u201323.","journal-title":"Mol Cell"},{"key":"7349_CR16","doi-asserted-by":"crossref","unstructured":"Nakamura M, Zhai P, Del RD, Maejima Y, Sadoshima J. Mst1-mediated phosphorylation of Bcl-xL is required for myocardial reperfusion injury. JCI Insight. 2016;1(5):e86217.","DOI":"10.1172\/jci.insight.86217"},{"issue":"18","key":"7349_CR17","doi-asserted-by":"publisher","first-page":"8993","DOI":"10.7150\/thno.62302","volume":"11","author":"W Wu","year":"2021","unstructured":"Wu W, Ziemann M, Huynh K, et al. Activation of Hippo signaling pathway mediates mitochondria dysfunction and dilated cardiomyopathy in mice. Theranostics. 2021;11(18):8993\u20139008.","journal-title":"Theranostics"},{"issue":"9","key":"7349_CR18","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1161\/01.RES.0000265846.23485.7a","volume":"100","author":"M Odashima","year":"2007","unstructured":"Odashima M, Usui S, Takagi H, et al. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction. Circ Res. 2007;100(9):1344\u201352.","journal-title":"Circ Res"},{"issue":"11","key":"7349_CR19","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1007\/s00125-016-4070-9","volume":"59","author":"M Zhang","year":"2016","unstructured":"Zhang M, Zhang L, Hu J, et al. MST1 coordinately regulates autophagy and apoptosis in diabetic cardiomyopathy in mice. Diabetologia. 2016;59(11):2435\u201347.","journal-title":"Diabetologia"},{"key":"7349_CR20","doi-asserted-by":"publisher","first-page":"628842","DOI":"10.3389\/fcell.2020.628842","volume":"8","author":"X Feng","year":"2020","unstructured":"Feng X, Wang S, Yang X, et al. Mst1 Knockout Alleviates Mitochondrial Fission and Mitigates Left Ventricular Remodeling in the Development of Diabetic Cardiomyopathy. Front Cell Dev Biol. 2020;8:628842.","journal-title":"Front Cell Dev Biol"},{"key":"7349_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejphar.2016.03.018","volume":"779","author":"S Gao","year":"2016","unstructured":"Gao S, Yang Z, Shi R, et al. Diabetes blocks the cardioprotective effects of sevoflurane postconditioning by impairing Nrf2\/Brg1\/HO-1 signaling. Eur J Pharmacol. 2016;779:111\u201321.","journal-title":"Eur J Pharmacol"},{"issue":"20","key":"7349_CR22","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1111\/bph.14795","volume":"176","author":"E Triastuti","year":"2019","unstructured":"Triastuti E, Nugroho AB, Zi M, et al. Pharmacological inhibition of Hippo pathway, with the novel kinase inhibitor XMU-MP-1, protects the heart against adverse effects during pressure overload. Br J Pharmacol. 2019;176(20):3956\u201371.","journal-title":"Br J Pharmacol"},{"issue":"5","key":"7349_CR23","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1161\/CIRCRESAHA.116.308736","volume":"119","author":"G Heusch","year":"2016","unstructured":"Heusch G, Rassaf T. Time to give up on cardioprotection? A critical appraisal of clinical studies on ischemic Pre-, Post-, and Remote conditioning. Circ Res. 2016;119(5):676\u201395.","journal-title":"Circ Res"},{"issue":"5","key":"7349_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00395-019-0747-9","volume":"114","author":"L Wu","year":"2019","unstructured":"Wu L, Tan JL, Chen ZY, Huang G. Cardioprotection of post-ischemic moderate ROS against ischemia\/reperfusion via STAT3-induced the inhibition of MCU opening. Basic Res Cardiol. 2019;114(5):39.","journal-title":"Basic Res Cardiol"},{"issue":"6","key":"7349_CR25","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1161\/01.CIR.101.6.660","volume":"101","author":"Y Fujio","year":"2000","unstructured":"Fujio Y, Nguyen T, Wencker D, Kitsis RN, Walsh K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation. 2000;101(6):660\u20137.","journal-title":"Circulation"},{"key":"7349_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fcell.2019.00211","volume":"7","author":"MM Mia","year":"2019","unstructured":"Mia MM, Singh MK. The Hippo signaling pathway in cardiac development and diseases. Front Cell Dev Biol. 2019;7:211.","journal-title":"Front Cell Dev Biol"},{"issue":"8","key":"7349_CR27","doi-asserted-by":"publisher","first-page":"904","DOI":"10.2174\/1389450116666150427154203","volume":"16","author":"ZV Varga","year":"2015","unstructured":"Varga ZV, Giricz Z, Bencsik P, et al. Functional genomics of cardioprotection by ischemic conditioning and the influence of comorbid conditions: implications in target identification. Curr Drug Targets. 2015;16(8):904\u201311.","journal-title":"Curr Drug Targets"},{"issue":"4","key":"7349_CR28","doi-asserted-by":"publisher","first-page":"942","DOI":"10.2337\/db15-0782","volume":"65","author":"H Li","year":"2016","unstructured":"Li H, Yao W, Liu Z, et al. Hyperglycemia abrogates ischemic postconditioning cardioprotection by impairing AdipoR1\/Caveolin-3\/STAT3 signaling in diabetic rats. Diabetes. 2016;65(4):942\u201355.","journal-title":"Diabetes"},{"key":"7349_CR29","doi-asserted-by":"publisher","first-page":"564902","DOI":"10.1155\/2013\/564902","volume":"2013","author":"M Liu","year":"2013","unstructured":"Liu M, Zhou B, Xia ZY, et al. Hyperglycemia-induced inhibition of DJ-1 expression compromised the effectiveness of ischemic postconditioning cardioprotection in rats. Oxid Med Cell Longev. 2013;2013:564902.","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"7349_CR30","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1042\/CS20150496","volume":"130","author":"R Xue","year":"2016","unstructured":"Xue R, Lei S, Xia ZY, et al. Selective inhibition of PTEN preserves ischaemic post-conditioning cardioprotection in STZ-induced Type 1 diabetic rats: role of the PI3K\/Akt and JAK2\/STAT3 pathways. Clin Sci (Lond). 2016;130(5):377\u201392.","journal-title":"Clin Sci (Lond)"},{"issue":"7","key":"7349_CR31","doi-asserted-by":"publisher","first-page":"5052","DOI":"10.1002\/jcp.30214","volume":"236","author":"J Zhang","year":"2021","unstructured":"Zhang J, Cai X, Zhang Q, et al. Hydrogen sulfide restores sevoflurane postconditioning mediated cardioprotection in diabetic rats: Role of SIRT1\/Nrf2 signaling-modulated mitochondrial dysfunction and oxidative stress. J Cell Physiol. 2021;236(7):5052\u201368.","journal-title":"J Cell Physiol"},{"issue":"2","key":"7349_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/apha.12874","volume":"221","author":"P Xie","year":"2017","unstructured":"Xie P, Yang L, Talaiti A, et al. Deferoxamine-activated hypoxia-inducible factor-1 restores cardioprotective effects of sevoflurane postconditioning in diabetic rats. Acta Physiol (Oxf). 2017;221(2):98\u2013114.","journal-title":"Acta Physiol (Oxf)"},{"key":"7349_CR33","doi-asserted-by":"publisher","first-page":"9213034","DOI":"10.1155\/2016\/9213034","volume":"2016","author":"J Lin","year":"2016","unstructured":"Lin J, Wang T, Li Y, et al. N-Acetylcysteine restores sevoflurane postconditioning cardioprotection against myocardial ischemia-reperfusion injury in diabetic rats. J Diabetes Res. 2016;2016:9213034.","journal-title":"J Diabetes Res"},{"issue":"4","key":"7349_CR34","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1161\/CIRCRESAHA.109.199919","volume":"105","author":"JW Calvert","year":"2009","unstructured":"Calvert JW, Jha S, Gundewar S, et al. Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res. 2009;105(4):365\u201374.","journal-title":"Circ Res"},{"issue":"1","key":"7349_CR35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0891-5849(89)90099-3","volume":"7","author":"BR Reddy","year":"1989","unstructured":"Reddy BR, Kloner RA, Przyklenk K. Early treatment with deferoxamine limits myocardial ischemic\/reperfusion injury. Free Radic Biol Med. 1989;7(1):45\u201352.","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"7349_CR36","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.117.027575","volume":"136","author":"S Pasupathy","year":"2017","unstructured":"Pasupathy S, Tavella R, Grover S, et al. Early use of N-acetylcysteine with nitrate therapy in patients undergoing primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction reduces myocardial infarct size (the NACIAM trial [N-acetylcysteine in acute myocardial infarction]). Circulation. 2017;136(10):894\u2013903.","journal-title":"Circulation"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-022-07349-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-022-07349-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-022-07349-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T08:11:32Z","timestamp":1702541492000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-022-07349-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,18]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["7349"],"URL":"https:\/\/doi.org\/10.1007\/s10557-022-07349-5","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,18]]},"assertion":[{"value":"30 May 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The care of animals and all animal experiments were implemented after being reviewed and approved by the Institutional Animal Use and Care Committee at Nanjing Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that there are no conflicts of interest regarding the publication of this article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}